Covaxin gets shelf life extension up to 12 months
DTMT Network
The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of shelf life of its coronavirus vaccine Covaxin up to 12 months from the date of manufacture, the vaccine maker Bharat Biotech informed on November 3, 2021.
“The CDSCO has approved the extension of shelf life of Covaxin up to 12 months, from the date of manufacture. This approval of shelf life extension is based on the availability of additional stability data, which was submitted to CDSCO,” Bharat Biotech informed in a tweet.
The shelf life extension has been conveyed to “our stakeholders,” the vaccine maker added.